Skip to main content

Table 1 Patient and treatment characteristics

From: Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma

Characteristic n (%) or median (range)
Sex
 Male 46 (82.14%)
 Female 10 (17.86%)
Age (years) 61 (34–84)
Karnofsky performance status (10%)
  ≤ 80 34 (60.71%)
  > 90 22 (39.29%)
Hepatitis B virus
 Positive 49 (87.5%)
 Negative 7 (12.5%)
Stagea
 II 13 (23.21%)
 III 25 (44.64%)
 IV 18 (32.14%)
Treatment strategy
 RT alone 9 (16.07%)
 RT combined with TACE 47 (83.93%)
Prescription dose for liver tumor (cGy) 5400 (4500–6200)
Live tumor(cm3) 151.81 (4.20–976.93)
Plan target volume for liver tumor(cm3) 342.29 (19.20–1442.27)
  1. V 5 volumetric proportion of spleen receiving ≥ 5 Gy
  2. aAmerican Joint Committee on Cancer staging manual, seventh edition. Frequency (percent proportions) are shown for all categorical variables and Medians (range) are shown for all continuous variables